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infectious defective interfering (DI) particles of the negative-stranded RNA virus vesicular stomatitis virus (VSV) have 
been recovered from negative-sense transcripts of a plasmid that contains a full-length cDNA derived from the DI-T particle 
genome. In order to determine the c/s-acting sequences necessary for RNA replication, encapsidation, and budding and to 
approximate the minimal size of RNA that can be packaged into infectious particles, we constructed a series of internal 
deletions in the DI cDNA to generate plasmids that could be transcribed to yield RNAs which ranged in size from 2209 
nucleotides down to 102 nucleotides. All the deletion plasmids retained at least 36 nucleotides from the 5'-terminus and 
51 nucleotides from the 3'-terminus of the DI genome. In cells expressing the five VSV proteins, the deleted DI RNAs were 
examined for their ability to be encapsidated, to replicate, and to bud to produce infectious DI particles. An RNA as small 
as 191 nucleotides, which contained 46 nucleotides from the 5'-end and 145 nucleotides from the 3'-end of the DI genome 
was encapsidated, replicated, and budded at least as efficiently as the full-length wild-type DI RNA. In contrast, a 102- 
nucleotide RNA that contained only the 51 nucleotides from the 5'-end of the DI RNA and its perfect 51-nucleotide comple- 
ment at the 3'-end replicated poorly and failed to bud infectious DI particles. However, an RNA with an insertion of 1499- 
nucleotide "stuffer" sequences of non-VSV origin between the two 51 -nucleotide complementary termini not only replicated 
but also budded infectious particles. These data show that the signals necessary for RNA encapsidation, replication, and 
packaging into infectious DI particles are contained within the 5'-terminal 36 nucleotides and the 3'-terminal 51 nucleotides 
of the DI RNA genome. Furthermore, the results show that a heterologous equence can be replicated and packaged into 
infectious particles if it is flanked by the DI RNA termini. © 1995 Academic Press, Inc. 
Defective interfering (DI) particles of vesicular stomati- 
tis virus (VSV) are generated during high multiplicity pas- 
sage of the virus in cells in culture. The genomes of 
these DI particles have large portions of the genomic 
RNA deleted and they vary significantly in structure and 
size (1-5). The DI particles interfere specifically with the 
replication of the standard homologous virus and play 
a major role in the establishment and maintenance of 
persistent infection (1, 6- 10). One of the best character- 
ized DI particles of VSV is the DI-T particle which was 
generated from the San Juan strain of the Indiana sero- 
type of VSV. The RNA of the DI particle is 2208 nucleo- 
tides in length and contains at its 5'-terminus 2163 nucle- 
otides from the 5'-terminus of the VSV genome and at 
its 3'-terminus, an inverted complement of the first 45 
nucleotides of the 5'-terminus of the VSV genome (3). 
Since the genome of the DI-T particle contains only a 
portion of the L gene, it lacks the genetic information to 
code for any of the viral proteins. However, it is an excel- 
lent template for RNA replication and has been used to 
examine the role and requirement for viral proteins in 
RNA replication and the assembly and budding of infec- 
tious particles (11- 17). 
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We have demonstrated that by transfecting a special- 
ized transcription plasmid (pDI) containing a cDNA copy 
of the DI RNA, it is possible to generate the DI RNA from 
pDI with a 3'-terminus identical to that of the authentic 
DI RNA. The DI RNA from pDI, if synthesized intracellu- 
larly in the presence of the five VSV proteins expressed 
by cotransfection of individual plasmids, can be encapsi- 
dated by the nucleocapsid protein N, replicated by the 
p01ymerase proteins P and L and in the presence of the 
matrix protein (M) and the glycoprotein (G), be assembled 
to generate infectious DI particles (18). To determine the 
cis-acting sequences necessary to signal RNA encapsi- 
dation, replication, and budding, we generated a series 
of internal deletion mutants of pDI and tested the ability 
of the mutants to be replicated and to bud to yield infec- 
tious particles. 
The construction of pDI has been reported (18). The 
DI cDNA contains 2209 nucleotides rather than 2208 nu- 
cleotides of the wt DI RNA, as it contains an additional 
A residue at position 22 from the 5'-end. A series of 
deletions was generated by the use of restriction enzyme 
recognition sites within the DI cDNA in pDI (Fig. 1). The 
sequences at the deletion junctions were determined 
by nucleotide sequencing of the deleted plasmid DNAs. 
These deletions were such that the negative-sense RNA 
transcripts made by T7 RNA polymerase would range in 
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DI Sequences 
Remaining (nt) 
5'-end 3'-end 
Heterologous Size of 
Sequences (nt) RNA (nt) 
@]0 ~"  6 T@ 
pDI Illillllllllil ol cDNA (2209 bp) V/~tlIIIItl I II All All 2209 
pDIA1 IIIIIIHII F / /~I I I I I I I I  II I 269 1891 2160 
pDIM2 ~ V//JlIIIIIIIII 36 1890 1926 
pDIA2. IIIIIllllllll I 1///~111111111 f I 262 1299 1561 
pD L,~3 III]1111111111 I I / /A I I I  Itll III 892 143 1035 
pDl~ IIIIIIIIIIIIII 1 I 1///~11111111111 254 122 376 
pDIA7 ~ I I~///11111 I I I II I 46 146 191 
pDI^8 ~ I r./jzdl ii i i ii i-i i 61 61 102 
pDIAS@ llllllllllllll I / J JA l i i l l l l l l  I 61 51 1499 1601 
FiG. 1. pDI deletion mutants and their derivatives, q~10 and T~ correspond to T7 RNA polymerase transcription initiation and termination signals. 
t~ corresponds to selfMcleaving ribozyme sequence from hepatitis delta virus. Arrow shows the position and direction of transcription by T7 RNA 
polymerase. 
size from 2160 nucleotides (pDIZ~l) down to 191 nucleo- 
tides (pDIz~7), which is less than 9% of the length of 
the DI genomic RNA. In each of the deletion mutants, 
however, at least 36 nucleotides from the 5'-terminus 
and 51 nucleotides from the 3'-terminus of the DI RNA 
were retained. Thus the termini of these RNAs were com- 
plementary for 36 to 45 nucleotides. The plasmid pDIA8 
was constructed by using the Aflll site at position 2158 
in the DI cDNA sequence and two plasmids containing 
the DI cDNA in opposite orientations. Exchange of re- 
striction fragments generated by digestion with Aflll and 
another restriction enzyme with a unique site within the 
vector sequence created pDIZ~8 containing 51 nucleo- 
tides at each terminus (Fig. 1). The transcript generated 
from pDIz~8 is therefore a 102-nucleotide-long RNA 
whose termini are perfectly complementary for 51 nucle- 
otides, 6 more than the 45 nucleotide-terminal comple- 
mentarity present in the wild-type DI RNA. The plasmid 
pDI2~8 was further modified by introducing an Aflll frag- 
ment of 1499 bp of bacteriophage ~X174 RF DNA into 
the unique Aflll site at the center of the two 51-nucleotide 
termini to generate the plasmid pDIA8~. All plasmids 
contained the T7 promoter positioned to transcribe the 
negative-sense DI RNA with two additional nucleotides 
(GG) at the 5'-terminus. The plasmids also contained the 
antigenomic ribozyme of hepatitis delta virus positioned 
to cleave the 3'-terminus of the transcripts immediately 
after the last VSV-specific nucleotide. All of these deleted 
plasmids and derivatives were examined for synthesis 
of RNA by the T7 RNA polymerase both in vitro and in 
transfected cells infected with the recombinant vaccinia 
virus (vTF7-3) expressing the T7 RNA polymerase (19) as 
described before (18). In each case, RNAs of appropriate 
sizes were generated following cleavage of the primary 
transcript by the ribozyme (data not shown). 
The ability of the RNAs transcribed in cells from each 
of the various pDI deletion constructs to be encapsidated 
and replicated by the VSV proteins N, P, and L was ana- 
lyzed. BHK-21 cells infected with vTF7-3 were transfected 
with plasmid DNAs containing the genes for the VSV 
proteins N, P, and L and the indicated pDI wild-type or 
deletion plasmids. The cells were exposed to [3H]uridine 
for 6 hr at 5 or 16 hr post-transfection. Results obtained 
by labeling at either of the two times were qualitatively 
the same. Cytoplasmic extracts were prepared and sub- 
jected to immunoprecipitation by anti-VSV antibodies 
which selects for encapsidated RNAs (18). The RNAs 
were recovered from immunoprecipitated nucleocapsids 
and analyzed by electrophoresis in agarose-urea gels 
as described previously (18). RNA is separated in these 
gels (run at pH 3.0) on the basis of both size and base 
composition, thereby allowing distinction of positive- and 
negative-sense RNA and direct visualization of replica- 
tion of the negative-strand RNA to yield a positive-strand 
RNA. A fluorogram of such a gel is shown in Fig. 2. The 
results showed that RNA generated from each of the 
deletion constructs was encapsidated and replicated. 
Replication of the negative-sense RNA transcript is evi- 
dent from the presence of a faster migrating RNA, which 
has been shown to correspond to the positive-sense 
product of RNA replication (18). A positive-sense RNA in 
addition to the negative-sense RNA was visible in all 
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FiG. 2. Intracellular replication of RNA from pDI deletion mutants. 
BHK-21 cells in 60-mm plates were infected with vTF7-3 (m.o.i. ~ 10) 
and subsequently transfected as described previously (18) with 3 fig 
of p-N, 2 /~g p-P, 1 fig p-L, and 5 fig of plasmid DNA for each pDI 
deletion construct as indicated at the top of each lane. Cells were 
labeled with 20 #Ci [3N]uridine per ml for 6 hr at 5 hr post-transfection, 
RNAs were recovered from nucleocapsids immunoprecipitated from 
cytoplasmic extracts, and analyzed by electrophoresis inagarose-urea 
gel. (A) Replication of RNA derived from plasmids pDl, pDIA1, pDIA12, 
pDIA2, pDIA3, and pDIA5 (Lanes 1-6, respectively). Lane 7 (DI-T) 
shows DI RNA replication products from cells transfected with N, P, and 
L plasmids and supednfected with authentic DI particles as described 
previously (13). (B) Replication of RNA derived from plasmids pDIA8, 
pDIA7, and pDI/',5 (Lanes 1-3, respectively). In vitro transcription prod- 
ucts made by T7 RNA polymerase in the presence of [3H]UTP from 
plasmids pDIz&8, pDIA7, and pDIA5 are shown in lanes 4-6. The gel 
in B was electrophoresed for 14 hr to retain smaller RNAs compared 
to 18 hr for A. (C) Replication of RNA from pDIA7 (Lane 1) and pDIA8 
(Lane 2) in the presence of actinomycin D. Transfected cells were 
treated with 10 #g of actinomycin D per ml for 30 min at 18.5 hr post- 
transfection and then labeled for 5 hr with [~H]uridine in the presence 
of actinomycin D. RNAs were analyzed as described above. "UC" repre- 
sents uncleaved primary transcript resent at the time of assay. 
cases, except DIA7 (Fig. 2B, lane 2) where the RNAs do 
not have a significantly different base composition to be 
resolved from one another, and DIA8 (Fig. 2B, lane 1) 
where the positive- and negative-strands are identical. 
Since the negative- and positive-sense DIA7 and 
DIA8 RNAs were not resolved from each other, it was 
not clear whether the RNAs in Fig. 2B, lanes 1 and 2 
were the products of replication by the VSV polymerase 
or simply the encapsidated transcripts generated by the 
T7 RNA polymerase. To distinguish between these possi- 
bilities, we treated the transfected cells with actinomycin 
D 30 min prior to and during labeling with [3H]uridine. 
Under these conditions, DNA-dependent RNA synthesis 
from transfected DNAtemplates directed byT7 RNA poly- 
merase is completely blocked and the only RNAs synthe- 
sized are due to replication of RNA by the VSV RNA 
polymerase (18). Results of such an experiment showed 
that DIA7 and DIA8 RNAs were synthesized in the pres- 
ence of actinomycin D (Fig. 2C, lanes 1 and 2), although 
DIZ&8 RNA replicated extremely poorly. Furthermore, 
when the P or L plasmid DNAwas omitted from transfec- 
tion during analysis of replication of these RNAs in the 
presence of actinomycin D, these RNAs were not synthe- 
sized at all (data not shown), confirming that both DIA7 
and DIA8 RNAs were replicated by the VSV RNA poly- 
merase, albeit very less efficient replication of DIA8 RNA. 
To examine whether the deleted RNAs shown to be 
encapsidated and replicated above could be assembled 
to bud infectious particles, cells were infected with vTF7- 
3 and then transfected separately with each of the pDI 
deletion constructs along with the plasmids for all five 
VSV proteins. At 24 hr post-transfection, the culture fluids 
were collected, clarified and assayed for the presence 
of infectious DI particles. The assay for the budded DI 
particles relies on their infectivity and has been de- 
scribed previously (12, 18). Briefly, fresh cells were in- 
fected with vTF7-3, transfected with the plasmids con- 
taining the N, P, and L genes, and then 5 hr later these 
cells were exposed to supernatant fluids from the previ- 
ous transfection. The infected cells were incubated in 
medium containing [3H]uridine for 6 or 16 hr before being 
harvested and assayed for synthesis of RNA. If infectious 
particles were released into the supernatant fluids of the 
first transfection, they would infect the new cells and 
replicate their genomic RNA using the N, P, and L pro- 
teins provided by the transfected plasmids. The results 
of this assay for infectious particles are shown in Fig. 
3. RNAs having the sizes corresponding to the deletion 
constructs used in the original transfection were synthe- 
sized in each of the cultures infected with the appropriate 
supematant fluids, with the exception of pDIA8. These 
data indicated that infectious DI particles were released 
from cells transfected with each of the pDI derivatives, 
except the smallest derivative, pDIA8. No RNA synthesis 
was detected in cells infected with culture fluids 
from pDIz&8-transfected cells (Fig. 3B, lane 2), although 
the ANA from pDIA8 replicated intracellularly (Fig. 20, 
lane 2). 
Two possible reasons to account for the finding that 
the 102 nucleotide DIA8 RNA replicated poorly and did 
not bud particles were that (i) the sequences necessary 
for efficient encapsidation and replication and/or assem- 
bly of DI RNA had been deleted from this molecule or 
(ii) there is a minimal size of RNA required to assemble 
and bud infectious particles. Alternatively, the failure to 
bud particles could be explained by the fact that the 51 
nucleotides at each terminus of this RNA were perfectly 
complementary to each other and therefore, such a mole- 
cule could fold back on itself or self-anneal to generate 
a double-stranded RNA which might be inefficiently en- 
capsidated, replicated, or assembled. However, it should 
be noted that larger DI RNAs with perfectly self-comple- 
mentary sequences, such as the genome of DI 011, occur 
naturally (20). We tested whether incorporation of "stuffer" 
sequences between the two termini of DIA8 RNA might 
restore the ability of the RNA to bud into infectious parti- 
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Fie. 3. Assembly and budding of infectious DI particles. BHK-21 cells 
in 60-mm plates were infected with vTF7-3 and transfected with 6 #g 
of p-N, 4 #g of p-P, 2 #g of p-L, 5 #g of p-M, 5 fig of p-G, and with 5 
#g of various pDI deletion constructs as indicated on top of each lane. 
Clarified culture fluids harvested from cells at 24 hr post-transfection 
were used to superinfect cells that had already been infected with 
vTF7-3 and transfected with N, P, and L plasmids. Replicating RNAs 
were labeled with [3H]uridine, isolated, and analyzed by electrophoresis 
as described in the legend to Fig. 2. (A) RNA replication by particles 
from pDl-, pDIAI-, pDIA12-, pDIA2-, pDIA3-, and pDIAS-transfected 
cells. (B) RNA replication by particles from pDIA7-, pDIA8-, and 
pDIA8~-transfected eNs. In vitro-synthesized RNAs are shown in 
lanes 5-7. (-) and (+) indicate particles ft untreated or treated, 
respectively, with anti-VSV antibody (1=100 dilution) for 2 hr at 4 ° before 
infection. "UC" indicates primary transcript that was not cleaved by the 
ribozyme at the time of assay. 
cles. We inserted 1499 bp of heterologous DNA from 
~X174 into the unique Aflll site in the center of pDIA8 
to create pDIA8~. When transcribed, pDIA8~b generated 
a 1601 nucleotide RNA that had the 51-nucleotide termini 
at either end as its only DI-specific sequences. In con- 
trast to the failure to detect infectious particles from cul- 
ture fluids of cells transfected with pDIA8 plasmid, the 
supernatant medium harvested from cultures transfected 
with pDIA8~ in the presence of all five proteins did con- 
tain infectious particles as shown by the replication of a 
1601 nucleotide RNA in the infectious particle assay (Fig. 
3B, lane 3). The infectivity of pDIA8q~ particles was neu- 
tralized when the culture fluid containing these particles 
was incubated in the presence of anti-VSV antibody (Fig. 
3B, lane 4), indicating that these particles were fully as- 
sembled and enveloped rather than subviral particles or 
naked nucleocapsids. Thus, incorporation of 1499 nucle- 
0tides of heterologous sequence between the two ter- 
mini of DIA8 RNA resulted in a replicable RNA (DIA8~) 
which could assemble and bud particles. These data 
demonstrate that the 51 nucleotides from each terminus 
of the VSV DI RNA are competent o signal RNA replica- 
tion, encapsidation, and assembly to bud infectious parti- 
cles and ruled out the possibility that essential c/s-acting 
sequences had been deleted from DIA8 RNA. In addi- 
tion, these data show that it is possible to include a 
heterologous sequence between these termini to pro- 
duce an RNA that can be encapsidated and replicated 
by the VSV RNA polymerase. 
The demonstration that only few nucleotides from the 
two termini of VSV DI RNA are sufficient o support RNA 
replication and assembly is in agreement with recent 
findings in other negative-strand RNA viruses like influ- 
enza (21), Sendal (22), respiratory syncytial virus (23), 
and human parainfluenza virus Type 3 (24). It has been 
demonstrated for these viruses that only 100 to 150 nu- 
elect/des or less from each terminus are sufficient to 
allow replication and assembly of infectious particles 
containing a foreign gene. Our data on VSV DI RNA sug- 
gest that 36 or fewer nucleotides from the 5'-terminus 
and 51 or fewer nucleotides from the 3'-terminus are 
sufficient to signal encapsidation, replication, and as- 
sembly of infectious particles. The data agree with previ- 
ous in vitro encapsidation studies which localized an 
encapsidation site for the leader RNA to the 5' terminal 
14 to 19 nucleotides (25, 26) and with studies in VSV- 
infected cells which suggest hat the smallest nucleocap- 
sid complex formed during nucleocapsid assembly con- 
tains 5'-terminal 65 nucleotides of viral-RNA (27). It ap- 
pears that for the negative-strand RNA viruses examined 
to date, the c/s-acting signals controlling transcription, 
replication, and encapsidation reside entirely within the 
two termini of their genomes. This observation is in direct 
contrast to what is known for positive-strand RNA vi- 
ruses. In addition to the terminal sequences, most posi- 
tive-strand RNA viruses require internal sequences for 
replication and packaging of their RNA (28-33). Short 
internal sequences of 78 nucleotides for flock house vi- 
rus RNA 2 (28) or 134 nucleotides for coronavirus defec- 
tive interfering particle RNAs (29) or multiple c/s-acting 
sequences located internally in Q/~ bacteriophage ge- 
nome (30) have been shown to be required for efficient 
RNA replication. For Sindbis virus also, internal se- 
quences have been shown to be required for encapsida- 
t/on and replication of the genomic RNA (33). Therefore, 
the c/s-acting sequences for RNA replication in negative- 
and positive-strand RNA viruses appear to be located 
differently. 
Our experiments demonstrated that exceedingly small 
DI RNAs were replicated and budded to generate parti- 
cles. Among the variety of naturally occurring DI particles 
of VSV, DI (0.10) containing approximately 1100 nucleo- 
tides appears to be the smallest (1, 4, 5). DIA7 RNA (191 
nucleotides), the smallest RNA budded into infectious 
particles here, is about six times smaller than DI (0.10) 
RNA and is less than 2% of the genome of VSV. It is 
possible that the lack of naturally occurring VSV DI parti- 
cles containing RNAs of this size is because they are 
outcompeted by other DI particles in the population. For 
Sendal virus DI particles, small size of the DI genome 
per se did not confer selective advantage for replication 
although there is evidence that selection might occur at 
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envelopment (34, 35). It should be possible now to exam- 
ine questions of DI RNA competition using the cDNA- 
based system where no wild-type virus is present. The 
envelopment and relative stability of different size DI ge- 
nomes during multiple passages also can be examined 
directly with or without the selective pressure of competi- 
tion. 
It has been reported for Sendal virus D! RNA replica- 
tion that only DI RNAs whose lengths are multiples of 
six nucleotides can be replicated (36). This finding was 
interpreted as a need for the nucleocapsid protein to 
contact exactly six nucleotides (36). Estimates of the 
mass and molecular composition reported for VSV sug- 
gest a stoichiometry of approximately nine nucleotides 
per N protein molecule (37) and since VSV has a helical 
nucleocapsid, it is reasonable to consider a spacing re- 
quirement for the N protein. However, in the work pre- 
sented here, the sizes of all the DI RNAs that replicate 
efficiently are not multiples of either six or nine. Similarly, 
the 11,161 nucleotide genome RNA of VSV is not a multi- 
ple of either six or nine, and examination of the sizes of 
several naturally occurring DI RNAs (4, 5) shows that not 
all of them are multiples of either six or nine. Thus, the 
results presented here show no evidence for a rigid num- 
ber of nucleotides per nucleocapsid protein molecule for 
VSV RNA replication, in contrast to the situation with 
Sendal virus. 
Taken together, the studies with the DI deletion mu- 
tants reported here show that 36 nucleotides or less from 
the 5'-terminus and 51 nucleotides or less from the 3'- 
terminus of the DI RNA are sufficient to signal encapsida- 
tion, replication, assembly, and budding of VSV DI parti- 
cles. Furthermore, a heterologous sequence placed be- 
tween these termini was encapsidated, replicated, and 
assembled into infectious particles, providing the first 
direct evidence that the termini are sufficient to signal 
these processes. 
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